Fempatch and Dysuria - a phase IV clinical study of FDA data
Summary:
We study 49,581 people who take Fempatch (estradiol) or have Dysuria. No report of Dysuria is found in people who take Fempatch.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Fempatch?
Fempatch has active ingredients of estradiol. eHealthMe is studying from 17 Fempatch users. Check the latest studies of Fempatch.
What is Dysuria?
Dysuria (painful or difficult urination) is found to be associated with 2,929 drugs and 2,510 conditions by eHealthMe. Check the latest studies of Dysuria.
No report is found.
Do you take Fempatch and have Dysuria?
- Check whether Dysuria is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Fempatch:
- Fempatch (17 reports)
Dysuria treatments and more:
- Dysuria (49,564 reports)
How severe was Dysuria and when was it recovered:
Expand to all the drugs that have ingredients of estradiol:
- Dysuria and drugs with ingredients of estradiol (267 reports)
Browse all side effects of Fempatch:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Dysuria:
Browse all the conditions that are associated with Dysuria:
How the study uses the data?
The study uses data from the FDA. It is based on estradiol (the active ingredients of Fempatch) and Fempatch (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Hot Flushes Aggravated and Dementia - 3 seconds ago
- Could Uniphyl cause Nasal Discharge Discoloration? - 4 seconds ago
- Antiphospholipid Syndrome and drugs of ingredients of ramipril - 8 seconds ago
- Drug interactions of Kaletra and Ciprofloxacin - 22 seconds ago
- Cefpodoxime Proxetil and Pantoprazole drug interactions for women aged 60+ - 23 seconds ago
- Abdominal Pain Aggravated and drugs of ingredients of hydrocortisone sodium succinate - 31 seconds ago
- Could Dexilant cause Occupational Exposure To Dust? - 38 seconds ago
- Could Ultram cause Injection Site Haematoma? - 39 seconds ago
- Could Avena Sativa cause Herpes Zoster? - 49 seconds ago
- Fatigue and drugs of ingredients of entacapone - 50 seconds ago